🌍 Macro & Market Dynamics

  • Oil likely to trend up ~6%, while QQQ faces a ~0.75% dip at open based on Weekend IG futures. 1
  • Food and energy prices are closely linked (“siblings”). Surging food costs historically ignite significant social unrest beyond mere inflation. 2
  • Peace talks or a resolution would trigger a market boom, at least temporarily. The challenge lies in timing this event, whether soon or at an $SPX level of 6,600. 4
  • Buffett’s investment philosophy emphasizes holding companies one fully understands. This approach, despite missing tech rallies, fosters conviction to average down during dips and has consistently beaten the S&P long-term. 20

🤖 AI & Semiconductor Sector Insights

  • NVIDIA’s latest Rubin AI chip demands ~300GB of memory (up from 80GB on H100), highlighting DRAM as a critical bottleneck in the AI buildout at hyperscaler scale. 19
  • The rise of “Agentic AI” signifies a CPU comeback, with 44% of workflows relying on CPU (3–4x conventional AI). This positions CPUs and memory as emerging bottlenecks. 24
  • AI compute’s next decade hinges on power, now the ultimate physical substrate. Unlike GPUs (from NVIDIA, AMD) or TPUs (GOOGL), gigawatts cannot be simply ordered, making power delivery the key differentiator. 30

📈 Individual Stock & Sector Deep Dives

  • SOFI plummeted from $33 to under $20 in early 2026, despite an 80%+ gain in 2025. This correction stems from cumulative factors: 16% share dilution via two large offerings, delayed rate cut expectations, and tech-finance sentiment hit by Bitcoin’s sharp pullback. 6
  • Investor sentiment often sours with lower stock prices. Many chased SOFI when it traded around $30 just two months prior. 11
  • Share issuance remains a common growth engine for many growth stocks, including Sofi, whose accelerating growth confirms the effectiveness of its offerings. 12
  • In volatile markets, a “first-principles” approach to investing is more robust. Among Mag7, Amazon and Microsoft mirror early 2025 Google’s setup, while NVIDIA, at ~$180 post its strongest earnings, appears undervalued. 13
  • $HIMS CEO forecasts the GLP-1 obesity drug market as a healthcare titan following $NVO partnership. Expects prices to plunge from ~$1,500/month to ~$50 due to rising supply and patent expiries. 15
  • $HIMS tops the list of largest companies with 35%+ short interest, marking it as a prime candidate for volatility. 17
  • $TMDX presents a rare setup: a “Big base + volatility contraction” chart pattern, often a precursor to significant moves. 18
  • $COST’s business model generates ~$16M daily before store opening, cementing the safety of its iconic $1.50 hot dog. 23
  • Unimicron Technology, an IC substrate maker, appears to be a “diamond-buying” opportunity. The company is securing volume over price through long-term contracts. 26